Alan Hervé

Alan Hervé’s practice focuses on private equity and French and cross-border M&A-related tax matters, including post-acquisition restructurings and integration transactions, as well as tax issues in connection with financing transactions and financial instruments.

Mr. Hervé’s experience since joining Skadden includes representing:

• KPMG Associés S.A. in connection with its agreement with TowerBrook Capital Partners regarding the sale of the entire share capital of KPMG ESC & GS

Mr. Hervé’s experience prior to joining Skadden includes representing:

• Sagard in connection with the sale of Aprium Pharmacie (France’s leading pharmacy brand) to Ardian
• Park Square Capital in connection with the sale of Terreal (a European manufacturer of clay roof tiles) to Wienerberger
• Eli Lilly in connection with the acquisition of Mablink (a French biotech company)
• Capza in connection with the acquisition of Biolam (a French medical biology laboratories group)
• Ardian in connection with the acquisition of a co-controlling stake in Odealim (a leader in real estate insurance and credit brokerage in France) alongside TA Associates
• iCON Infrastructure in connection with the implementation of the Portsynergy (Le Havre Port) joint venture with Terminal Link
• Montagu in connection with the acquisition of Eudonet (a developer of CRM software)
• InfraVia Capital Partners in connection with the acquisition of Grandir (a leading international childcare platform operating under the brand Les Petits Chaperons Rouges)